Articles by Michael Hanson

Mike is Senior Vice President of Research and a member of Fisher Investments’ five-person Investment Policy Committee. He is the author of six books, including 20/20 Money: See the Markets Clearly, Gain Focus and Invest Better than the Pros. Mike joined the firm in 2002.

Investors Look To Capitalize On Biden’s $2.3 Trillion Infrastructure Plan

U.S. President Joe Biden’s pledge to spend $2.3 trillion on infrastructure has investors wondering how to position themselves to benefit. Fisher Investments’ Mike Hanson explains why traditional infrastructure funds may not be the best way to capitalize on the spending plans.

Read More

Vaccine Rollout May Limit Upside For Global Industrial Stocks

The industrial sector escaped much of the pain felt by services businesses in the past year, as consumers used their spare time - and money - to purchase manufactured goods. Mike Hanson of Fisher Investments explains why he thinks vaccine rollouts may limit the upside for the sector.

Read More

Trading At Noon: Jobless Numbers Show Labour Market Still Weak

The U.S. labour market remains weak, with a seasonally adjusted 793,00 people filing jobless claims last week, adding new impetus to call for a major stimulus package – but Mike Hanson of Fisher Investments told us it won’t necessarily boost Americans’ spending for very long.

Read More

Financial Sector’s Bumpy Ride May Continue In 2021

Financial stocks globally under-performed the wider market last year, but with the economy set for a post-pandemic rebound will their prospects also improve? Fisher Investments’ Mike Hanson explains why he thinks investors should still be wary of the sector.

Read More

Trading at Noon: Democrat wins boost stimulus hopes, Wall Street

Wall Street benchmarks rose on Thursday on optimist that more pandemic aid is on its way now that Democrats control both the White House and Congress.

Read More

Trading At Noon: Sprint For Coronavirus Vaccine Lights Up Wall Street

Wall Street benchmarks are higher after Moderna and Pfizer both applied for emergency approval in Europe to use their vaccines.

Read More

Trading At Noon: Wall Street Mixed Amid Surge In Coronavirus Cases

Wall Street benchmarks were mixed on Thursday, with stay-at-home stocks once again propping up in the Nasdaq. Financials led the S&P 500 lower after the U.S. recorded another record day of coronavirus cases and hospitalizations.

Read More

Reality And Expectations: 2020 Revealed Your True Risk Tolerance

It may never get better than 2020 to know yourself as an investor. COVID-19, dastardly in its ability to spread so readily and affect so many, not only creates money problems—it creates real existential threat. Couple that with the most contentious US election in memory, and you have a veritable (albeit emotionally painful) lab to test your true risk tolerance.

Read More

Five Spooky Reads To De-Ghoul Your Portfolio

In honor of Halloween, Dia De Los Muertos, or whichever way you celebrate the darker side of things, here are five great books to take the scare out of your portfolios.

Read More

Little Market Movement Will Happen If Stimulus Passes, Investor Says

Senate Majority Leader Mitch McConnell just unveiled the Republicans' new trillion-dollar stimulus plan, calling for a reduction to the $600 unemployment boost. Mike Hanson, SVP of Research at Fisher Investments, joined Cheddar to discuss.

Read More